ProCE Banner Activity

Frequently Asked Questions on Recent Approvals and Novel Therapies in Cervical Cancer

Clinical Thought

Read this commentary from cervical cancer experts discussing recent approvals and adverse events management recommendations for novel therapies in patients with cervical cancer.

Released: June 09, 2022

Expiration: June 08, 2023

Begin Activity



Maria Avila-Wallace

Maria Avila-Wallace, NP

Nurse Practitioner
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Massachusetts General Hospital
Boston, Massachusetts

Lauren Prescott

Lauren Prescott, MD

Assistant Professor
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Vanderbilt University Medical Center
Nashville, Tennessee


This activity is supported by an educational grant from Genmab and Seagen.

Target Audience

Oncology NPs, PAs, and nurses


Maria Avila-Wallace, NP, has no relevant financial relationships to disclose.

Lauren Prescott, MD: consultant: Tempus.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.




The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.

Additional Information

Program Medium

This program has been made available online.